RxDoctor Payments Data

Kelsey Ackerman

Family · Haslet, TXNPI 1952893539

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 76 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 22.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $557 and has fallen 85.3% since, to $82 in 2025.

$1,346in general payments, 2019–2025

Across 76 payments — averaging $17.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$307
  • Johnson & Johnson$180
  • Amarin Pharma, Inc.$136
  • Lilly USA, LLC$113
  • Boehringer Ingelheim$83
  • Novo Nordisk$79
  • plus $447 from 18 others

What the payments were for

  • Food & beverage$1,346100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,346 in reported general payments places this provider in the 70th percentile of 15,456 family providers in Texas.

See all family providers in Texas →

Other family in Haslet

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →